Development of pyrimidine-based inhibitors of Janus tyrosine kinase 3.
2006
A new class of pyrimidine-based Janus tyrosine kinase 3 (JAK3) inhibitors are described. Many of these inhibitors showed low nanomolar activity against JAK3.
Keywords:
- Correction
- Source
- Cite
- Save
- Machine Reading By IdeaReader
8
References
34
Citations
NaN
KQI